KCAS Bio will be attending the International Clinical Cytometry Meeting (ICCS) 2025 on September 26-30 in Philadelphia, PA. This annual meeting brings together leaders and scientists to advance the understanding and application of technologies and methodologies in patient sample analysis.
Through presentations and collaborative discussions, attendees will explore the latest breakthroughs, tools, and best practices driving progress in clinical cytometry.
Driving Innovation in Clinical Cytometry at KCAS Bio
KCAS Bio strives to bring excellence and innovation to the clinical cytometry field. Leveraging high-parameter platforms, we can support deep cellular profiling for immunophenotyping, biomarker discovery, and cell sorting. With global expertise and regulatory strength, KCAS Bio delivers high-quality insights to the advancements of clinical cytometry.
Our attendance in ICCS 2025 allows us to connect with other experts to discuss the ultimate goal of progressing in the field of cytometry.
Let’s Connect at ICCS 2025
If you plan to attend ICCS 2025, connect with us throughout the event. One of our leaders, Karla Moncada will be present and ready to discuss how the advancements and applications of cytometry can best suit your studies. Whether you are studying cell signaling, immune response, or cell cycle dynamics, Karla will explore how KCAS Bio’s solutions can fit your specific research needs.